Powered by

INVO Bioscience Signs Joint Venture Agreement with Medesole Healthcare and Trading Pvt Ltd to Operate Dedicated INVOcell Fertility Clinics in India; Joint Venture Targets Rapidly Growing India Market for Infertility Services

Jan 16, 2020 - PR Newswire

PR Newswire

INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, and Medesole, a leading supplier of healthcare products in India and the Middle East, today announced the signing of a joint venture to operate dedicated INVOcell clinics in India.  INVOcell, also known as IVC, is the world's onlyin vivoIntravaginal Culture System, offering patients diagnosed with infertility an effective solution through a sim...